Engineered nanoparticles induce cell apoptosis: potential for cancer therapy.

Area of Science:

• Nanotechnology
• Biomedical Engineering
• Toxicology

Background:

• Engineered nanoparticles (ENPs) are increasingly used in various fields, including medicine and industry.
• ENPs, particularly those under 100 nm, can penetrate the human body and accumulate in organs, potentially causing toxic effects.
• Previous studies have documented ENP-induced cell apoptosis in different organs.

Purpose of the Study:

• To understand the pathways of ENP-induced apoptosis.
• To explore the potential of ENPs in cancer therapy, either directly or as drug delivery agents.
• To investigate how ENP characteristics influence toxicity and how to mitigate it.

Main Methods:

• Review of existing literature on ENP toxicity and cellular effects.
• Analysis of studies investigating ENP-induced apoptosis pathways.
• Examination of the relationship between ENP characteristics (size, shape, charge, surface modification) and toxicity.

Main Results:

• ENPs can induce cell apoptosis and accumulate in vital organs.
• ENP characteristics significantly influence their toxicity and cellular interactions.
• Specific modifications can reduce ENP cytotoxicity without compromising their intended therapeutic or delivery functions.

Conclusions:

• Understanding ENP-induced apoptosis is crucial for developing safer nanomedicines.
• Tailoring ENP properties offers a strategy to minimize off-target toxicity.
• ENPs hold promise for targeted cancer therapy if toxicity is carefully managed.